greeksoup/ stock research

Interface Inc.: Q3 FY2026 earnings call

What management said about Q3 FY2026, from the documents filed with the SEC on 6 November 2026: press release. Guidance figures: 6 lowered, 1 kept. The quarter’s numbers.

Key takeaways

  • Net sales grew modestly: Net sales were $366.7 million, up 0.6% from $364.5 million a year earlier, or 0.4% currency neutral. Nine-month net sales were $1,093.5 million, up 5.4%. Source
  • Adjusted EPS up, GAAP EPS down: Adjusted diluted EPS was $0.68, up 11.5%. GAAP diluted EPS was $0.67, down 14.1%. The prior-year quarter included a $10.4 million non-cash German deferred tax credit that the company excludes from adjusted results. Source
  • Healthcare billings led growth: Global billings grew in all three primary market segments. Healthcare billings rose 5%, on top of 29% growth in the prior-year quarter. Source
  • Gross margin rose on pricing, mix: Adjusted gross profit margin was 40.6%, up 103 basis points from 39.5%. GAAP gross margin was 40.6%, up 116 basis points from 39.4%. Source
  • Net debt fell sharply: Total debt was $130.2 million at October 4, 2026, against $181.6 million at fiscal year-end. Cash was $81.1 million, and net debt was $49.1 million, against $110.3 million. The net leverage ratio was 0.2x. Source
  • Full-year earnings guidance reaffirmed: The company reaffirmed full-year earnings guidance, citing strong operational execution during the year. Source
  • Full-year net sales guidance lowered: Full-year net sales guidance was revised to $1.440 to $1.455 billion from $1.455 to $1.485 billion, reflecting softer conditions in Europe. Source

“With our ongoing investments in innovation, productivity, and operational efficiency, we remain confident in our ability to drive growth, expand margins, and create value for our stakeholders”

Laurel Hurd, CEO of Interface

Guidance

AreaPeriodFigureAgainst last quarter
Net sales SourceFull fiscal year 2026$1.440 to $1.455 billionLowered from $1.455 to $1.485 billion
Adjusted gross profit margin SourceFull fiscal year 202640.4% of net salesLowered from 40.6% of net sales
Adjusted SG&A expenses SourceFull fiscal year 2026$387 millionLowered from $395 million
Adjusted interest & other expenses SourceFull fiscal year 2026$14 millionLowered from $15 million
Adjusted effective income tax rate SourceFull fiscal year 202625.0%Lowered from 26.0%
Capital expenditures SourceFull fiscal year 2026$60 millionKept
Fully diluted weighted average share count SourceFull fiscal year 202658.5 million sharesLowered from 58.6 million shares

What changed from last quarter

  • Guidance lowered: Full-year net sales guidance moved from $1.455 to $1.485 billion to $1.440 to $1.455 billion. Source
  • Guidance lowered: Full-year adjusted gross margin, adjusted SG&A, adjusted interest and other expense, tax rate and diluted share count guidance were each revised down. Source
  • Guidance kept: Full-year earnings guidance was reaffirmed, and capital expenditure guidance stayed at $60 million. Source

Quarter results and growth

  • Net sales grew modestly: Net sales were $366.7 million, up 0.6% from $364.5 million a year earlier, or 0.4% currency neutral. Nine-month net sales were $1,093.5 million, up 5.4%. Source
  • Adjusted EPS up, GAAP EPS down: Adjusted diluted EPS was $0.68, up 11.5%. GAAP diluted EPS was $0.67, down 14.1%. The prior-year quarter included a $10.4 million non-cash German deferred tax credit that the company excludes from adjusted results. Source
  • Adjusted operating income and EBITDA rose: Adjusted operating income was $57.2 million, up 5.7%. Adjusted net income was $39.9 million, up 11.1%. Adjusted EBITDA was $69.3 million, up 4.7%. Source
  • Adjusted earnings ahead of expectations: The CFO said adjusted earnings growth ran ahead of the company's own expectations, even with modest net sales growth in the quarter. Source

Segments and regions

  • AMS sales rose slightly, orders grew: AMS net sales were $219.4 million, up 0.3%, or 0.5% currency neutral. AMS currency-neutral orders rose 6.2%. AMS operating income was $41.2 million, up 1.8%. Source
  • EAAA orders fell, profit rose: EAAA net sales were $147.4 million, up 1.0%, or 0.3% currency neutral. Currency-neutral orders fell 6.8%. Adjusted operating income rose 17.0% to $16.0 million. Source
  • Americas momentum offset EMEA softness: Management attributed the offset to momentum in the Americas, disciplined execution and the One Interface strategy, against softer conditions in EMEA during the quarter. Source
  • Nine-month segment sales grew: Nine-month AMS net sales rose 3.9% to $662.7 million. EAAA net sales rose 7.8% to $430.8 million, or 2.9% currency neutral, and EAAA adjusted operating income rose 47.3% to $38.8 million. Source

“Our backlog is solid, our balance sheet is healthy, and we remain focused on margin expansion and cost discipline.”

Bruce Hausmann, CFO of Interface

Customers, billings and orders

  • Healthcare billings led growth: Global billings grew in all three primary market segments. Healthcare billings rose 5%, on top of 29% growth in the prior-year quarter. Source
  • Education and offices grew slightly: Education and Corporate Office billings each grew in the low single digits. Source
  • Some Retail and nora deliveries shifted: The CFO said certain Retail and nora deliveries moved into future periods, which kept net sales growth modest in the quarter. Source
  • Orders rose 0.8% currency neutral: Company-wide currency-neutral orders rose 0.8% year over year, compared with 5.4% in the second quarter. Source
  • Backlog described as solid: The CFO described the backlog as solid and said the company remains focused on margin expansion and cost discipline. Source

Costs, margins and pricing

  • Gross margin rose on pricing, mix: Adjusted gross profit margin was 40.6%, up 103 basis points from 39.5%. GAAP gross margin was 40.6%, up 116 basis points from 39.4%. Source
  • SG&A rose on inflation, marketing: Adjusted SG&A expenses rose $1.5 million to $91.5 million, or 1.7%, and were 25.0% of net sales against 24.7% a year earlier. Source
  • Raw material and tariff costs offset: Higher raw material and tariff-related costs partly offset the margin gain. Source
  • Nine-month gross margin up sharply: Nine-month adjusted gross profit margin was 41.5%, up 238 basis points from 39.1%. Nine-month adjusted operating income rose 21.7% to $164.9 million. Source

“Together, these position us to deliver long-term, sustainable growth”

Bruce Hausmann, CFO of Interface

Capital, cash and shareholder returns

  • Net debt fell sharply: Total debt was $130.2 million at October 4, 2026, against $181.6 million at fiscal year-end. Cash was $81.1 million, and net debt was $49.1 million, against $110.3 million. The net leverage ratio was 0.2x. Source
  • Operating cash flow rose: Cash provided by operating activities was $86.3 million in the quarter, against $76.7 million a year earlier, and $138.2 million for nine months, against $118.6 million. Source
  • Capital spending and full-year target: Capital expenditures were $9.1 million in the quarter and $31.6 million for nine months. Full-year capital expenditure guidance is $60 million, unchanged. Source
  • No buybacks in the quarter: The company repurchased no common stock in the third quarter. Nine-month repurchases totaled $20.8 million. Dividends paid were $1.7 million in the quarter. Source

Strategy and investment

  • One Interface strategy continues: Management said the One Interface strategy continues to drive shareholder value. Source
  • Investment in innovation and efficiency: The CEO cited ongoing investment in innovation, productivity and operational efficiency as support for growth, margin expansion and value creation. Source
  • Backlog supports long-term growth: The CFO said the backlog and balance sheet position the company for long-term, sustainable growth. Source

Full-year guidance revisions

  • Full-year earnings guidance reaffirmed: The company reaffirmed full-year earnings guidance, citing strong operational execution during the year. Source
  • Full-year net sales guidance lowered: Full-year net sales guidance was revised to $1.440 to $1.455 billion from $1.455 to $1.485 billion, reflecting softer conditions in Europe. Source
  • Margin, SG&A and interest lines lowered: Full-year adjusted gross margin is 40.4% against 40.6%. Adjusted SG&A is $387 million against $395 million. Adjusted interest and other expense is $14 million against $15 million. Source
  • Tax rate and share count lowered: Full-year adjusted effective tax rate is 25.0% against 26.0%. Diluted share count is 58.5 million against 58.6 million. Source
  • Tariff refunds included in guidance: Full-year guidance includes $15.6 million of IEEPA tariff refunds received in the second quarter of 2026. Source

Figures management reported

FigureReported
Currency-neutral orders increase, consolidated Source0.8%
Currency-neutral orders increase, AMS segment Source6.2%
Currency-neutral orders change, EAAA segment Source(6.8)%
Healthcare billings increase Source5%

Risks management discussed

  • Demand: Net sales guidance was reduced because of softer conditions in Europe. Source
  • External: Higher raw material and tariff-related costs partly offset margin gains this quarter. Source
  • Operational: Some Retail and nora deliveries moved into future periods, which limited net sales growth this quarter. Source
  • Financial: Higher inflation and marketing costs increased adjusted SG&A expenses in the quarter. Source

Earlier plans management reported on

  • Ahead: Management said adjusted earnings growth ran ahead of its own expectations. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.